Next Article in Journal
Type 1 Diabetes: Interferons and the Aftermath of Pancreatic Beta-Cell Enteroviral Infection
Previous Article in Journal
Proline-Rich Hypervariable Region of Hepatitis E Virus: Arranging the Disorder
Previous Article in Special Issue
A Novel System for Real-Time, In Situ Monitoring of CO2 Sequestration in Photoautotrophic Biofilms
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Characterization of the Bacterial Biofilm Communities Present in Reverse-Osmosis Water Systems for Haemodialysis

by
Juan-Pablo Cuevas
1,
Ruben Moraga
2,
Kimberly Sánchez-Alonzo
3,
Cristian Valenzuela
1,
Paulina Aguayo
4,5,
Carlos T. Smith
3,
Apolinaria García
3,
Ítalo Fernandez
1 and
Víctor L Campos
1,*
1
Environmental Microbiology Laboratory, Department of Microbiology, Faculty of Biological Sciences, University of Concepción, Concepción 4070386, Chile
2
Microbiology Laboratory, Faculty of Renewable Natural Resources, Arturo Prat University, Iquique 1100000, Chile
3
Laboratory of Bacterial Pathogenicity, Department of Microbiology, Faculty of Biological Sciences, Universidad de Concepcion, Concepcion 4070386, Chile
4
Faculty of Environmental Sciences, EULA-Chile, Universidad de Concepcion, Concepcion 4070386, Chile
5
Institute of Natural Resources, Faculty of Veterinary medicine and agronomy, Universidad de Las Américas, Sede Concepcion, Chacabuco 539, Concepcion 3349001, Chile
*
Author to whom correspondence should be addressed.
Microorganisms 2020, 8(9), 1418; https://doi.org/10.3390/microorganisms8091418
Submission received: 15 July 2020 / Revised: 14 August 2020 / Accepted: 19 August 2020 / Published: 15 September 2020
(This article belongs to the Special Issue Mono- and Multi-Species Biofilms in Bioprocesses)

Abstract

:
Biofilm in reverse osmosis (RO) membranes is a common problem in water treatment at haemodialysis facilities. Bacteria adhere and proliferate on RO membranes, forming biofilms, obstructing and damaging the membranes and allowing the transfer of bacteria and/or cellular components potentially harmful to the health of haemodialysis patients. Our aim was to characterize the bacterial community associated to biofilm of RO membranes and to identify potentially pathogenic bacteria present in the haemodialysis systems of two dialysis centres in Chile. The diversity of the bacterial communities present on RO membranes and potable and osmosed water samples was evaluated using Illumina sequencing. Additionally, bacteria from potable water, osmosed water and RO membrane samples were isolated, characterized and identified by Sanger’s sequencing. The molecular analyses of metagenomics showed that the phyla having a greater relative abundance in both dialysis centres were Proteobacteria and Planctomycetes. Pseudomonas, Stenotrophomonas, Agrobacterium, Pigmentiphaga, Ralstonia, Arthrobacter, Bacteroides and Staphylococcus were bacterial genera isolated from the different samples obtained at both haemodialysis centres. Pseudomonas spp. was a bacterial genus with greater frequency in all samples. Pseudomonas and Staphylococcus showed higher levels of resistance to the antibiotics tested. Results demonstrated the presence of potentially pathogenic bacteria, showing resistance to antimicrobials on RO membranes and in osmosed water in both dialysis centres studied.

1. Introduction

Since the incidence of chronic renal failure is increasing around the world, the number of individuals requiring treatment for end-stage renal disease is also rising [1]. Haemodialysis (HD) is the main treatment for patients with severe renal failure. Patients undergoing HD are subjected to large volumes of dialysis fluid (approximately 120 L) in a single dialysis treatment [2].
Considering the repeated large volumes of water each patient is subjected to, ensuring the necessary quality of dialysate solution is a vital aspect for a safe HD because chemical, bacterial and associated endotoxin and bacterial debris contamination can threaten the health of a patient requiring this treatment [3]. Moreover, dialysis patients often have additional comorbidities (e.g., diabetes, hypertension and cardiovascular disease) making them more vulnerable to adverse outcomes [4]. Therefore, the microbiological quality of water present in the accumulation tanks at the dialysis centres is of utmost concern. The Association for the Advancement of Medical Instrumentation (AAMI) recommendations for conventional dialysis water includes its microbiological quality, requiring <100 CFU mL−1 total heterotrophic bacteria viable count and <0.25 UE mL−1 for endotoxins [5]. In Chile, similar standards are required for HD water, i.e., <100 CFU mL−1 total heterotrophic bacteria viable count and <0.03 UE mL−1 for endotoxins [5].
Dialysis centres have water accumulation tanks that receive potable water (PW) and supply it to the water pre-treatment system. PW, after passing through physicochemical processes, is subjected to treatment through reverse osmosis (RO). This system uses spirally wounded Thin Film Composite (TFC) membranes, a type of membrane commonly used for water reconditioning. RO membranes are highly efficient, removing approximately 99% of the bacteria present in water treatment systems [6]. Nevertheless, biofouling and flow reduction, caused by microorganisms capable to form biofilms on them, are well-known disadvantages of RO membranes causing their malfunction [7,8] and allowing the transfer of bacteria and endotoxins to dialysed water, a possible hazard for the health of patients undergoing HD [9,10].
During biofilm formation, free-swimming (planktonic) bacteria become firmly attached to surfaces, grow and recruit more planktonic cells [11]. Microbial biofilms contain bacterial cells and extracellular polymeric substances including polysaccharides, proteins and nucleic acids. This matrix favours the adhesion of microorganisms and protects them from various stresses and severe environmental conditions. Biofilms present on RO membranes are multi-genera and they are often thicker and more resistant to antibiotics and other antimicrobial compounds than biofilms formed by only one bacterial genus [2,4,9,11]. Besides being important in microbial ecology, bacterial adhesion is also important in biotechnology, biofouling and wastewater treatment. The ability of bacteria to interact with surfaces depends on particular molecules or structures present on their outer surface. These may be outer membrane proteins or lipopolysaccharides, proteinaceous appendages (fimbriae or flagella) or complex carbohydrates of extracellular capsules [4].
Biofilm of RO membranes have not only an economic negative impact for dialysis centres but also for the health of HD patients. The presence of multi-drug resident bacteria and persistent bacteria in biofilm has been poorly studied, and considering the risk they signify to patients, the aim of the present work was to characterize the bacterial communities associated to the water and RO membranes from two haemodialysis treatment centres and to identify potentially pathogenic bacteria and to determine their resistance to antimicrobials.

2. Materials and Methods

2.1. Sampling

Samples were collected at two dialysis centres located in the north-central area (DCN) and south-central area (DCS) of Chile. Both centres are located approximately 500 km apart. Samples, 1 L each by triplicate, of potable water (PW) and of osmosed water (OW) stored in the accumulation tanks were collected. Further processing of samples was also processed by triplicate. Reverse osmosis (RO) membranes were also collected. Water samples and RO membranes were transported, at 4 °C, to the Laboratory of Environmental Microbiology, Faculty of Biological Sciences, University of Concepcion, Concepcion, Chile, and stored at that same temperature until further analysis. In order to determine the total and heterotrophic bacterial counts from the RO membranes, two samples of 10 cm2 each were aseptically obtained in a laminar flow hood (ZHJH-C 1109C, Zhi cheng, Shangai, Korea) from their initial, middle and final sections, hereon referred as membrane segments A, B or C, respectively. Furthermore, sets of RO membrane segments were obtained for microscopic analysis.

2.2. Scanning Electron Microscopy

To study the segments of RO membranes under scanning electron microscopy (SEM), they were washed three times using sterile saline solution and fixed with 2.5% glutaraldehyde. After dehydration, the samples were critical point dried using CO2 and coated with gold (S150 Sputter Coater, Edwards/Kiese, Germany). Samples were analysed using a JEOL JSM 6380LV SEM (JEOL, Tokyo, Japan).

2.3. Total and Heterotrophic Bacterial Counts

To quantify the total and heterotrophic bacterial counts present in RO membranes, it was necessary to previously sonicate segments of RO membranes in 100 mL phosphate-buffered saline (PBS) (pH 7.0) in an ultrasonic bath (Elma/S30, Singen, Germany) adjusted at 100 W for 2 min.
To determine total bacterial counts, 10 mL samples (from PW, OW or previously sonicated RO segments) were fixed in formaldehyde solution (4% w/v) and filtered using white polycarbonate membranes (0.2 μm, Ø47 mm). DAPI (4,6-diamino-2-phenylin doldihydrochloride dilactate) staining was added to a final concentration of 1 mg mL-1. Bacterial cells were counted using a Motic BS-310 epifluorescence microscope equipped with a MotiCam Pro 285A digital camera (Motic, Richmond, Canada).
To count heterotrophic bacteria, 100 mL of samples (from PW, OW or previously sonicated RO segments) were place on Plate Count Agar (PCA) (Merck, NJ, USA) and incubated at 37 °C. The results were read at 44 ± 4 h, as recommended by the Standing Committee of Analysts, United Kingdom guidelines (Environment Agency 2012).

2.4. Polymerase Chain Reaction (PCR)-Denaturing Gradient Gel Electrophoresis (DGGE) and Analysis of DGGE Profiles

Total DNA from RO membrane segments and from water (PW and OW) was extracted using the UltraClean soil DNA extraction kit (MO BIO Laboratories Inc., Carlsbad, CA, USA) following the protocol provided by the manufacturer. Total DNA of each sample was amplified using 16S rRNA universal primers EUB 9–27 and EUB 1542 (Guzmán-Fierro et al. 2015) [12]. Nested PCR was performed using the primer pair 341f and 534r with a GC clamp (CGCCC GCCGC GCGCG GCGGG CGGGG CGGGG GCACG GG GGG) according to Mafla et al. [13]. DGGE was done using a DGGE 1001 system (C.B.S. Scientific Company Inc., San Diego, USA) according to Campos et al. [14].
For DGGE profile analyses, DGGE gels were digitized using a photo-documentation system MaestroGen (MaestroGen Inc., Hsinchu, Taiwan). The bands were scored as present or absent at each position in the gel, using the Gel-Pro Analyzer 4.0 software package (Media Cybernetics, Silver Spring, MD, USA). For the analysis of banding profiles, a binary matrix was constructed based on the presence (1) or absence (0) of individual bands in each lane. A multidimensional scaling diagram (MDS) was constructed using the Bray Curtis algorithm, according to Guzman-Fierro et al. (2015) [12].

2.5. Genomic DNA Extraction and 16S rRNA Gene Massive Sequencing

Genomic DNA was extracted directly from PW and OW samples and from the three segments of RO membranes of both dialysis centres using the PowerSoil DNA kit (MoBio, Carlsbad, CA, USA) according to the manufacturer’s instructions. The DNAs extracted were subsequently purified using the UltraClean 15 DNA Purification Kit (MoBio, Carlsbad, CA, USA). The quality and concentration of DNAs were checked by UV/Vis spectroscopy (NanoDrop ND-1000, Peq-lab, Erlangen, Germany).
Total DNA extracted from RO membranes (combination of the three segments) and PW samples of the two-dialysis centres were quantified and sequenced. The DNA extracted from OW samples was not sufficient to perform the assays. Illumina sequencing was performed at Genoma Mayor, Universidad Mayor, Santiago, Chile. The raw data was analysed using the Mothur bioinformatics analysis software (version 1.35.1; https://mothur.org) using, unless indicated, default options. Reads under 200 bp were discarded. Denoising of reads was achieved using the Mothur’s platform “pre.cluster” command to remove sequences probably caused by errors and assemble reads differing only by 2bp. Chimeric sequences were identified and removed using the UCHIME algorithm [15]. The remaining sequences were classified using the SILVA database.

2.6. Bacterial Isolation

PW and OW samples were concentrated using 0.22 μm cellulose nitrate filters (Corning Inc., NY, USA). Then the filters were sonicated in a bath (Elmasonic P 120 H ultrasonic, Singen, Germany) containing 10 mL PBS, pH 7.0. Segments of RO membranes were also sonicated in the same buffer mentioned above. For isolation of bacterial strains, 100 µL of each sonicated filter or RO membrane segment were disseminated on the surface of Petri dishes containing BBL nutritive agar (Becton-Dickinson and Company, NJ, USA). Plates were incubated at 30 °C for 24–48 h under aerobic conditions. The selected colonies were stored at −80 °C for further analysis.

2.7. Identification of Heterotrophic Aerobic Bacteria

DNA was extracted from the bacterial isolates using the InstaGene Matrix kit (BIO-RAD, Hercules, CA, USA), according to the manufacturer’s indications. Bacterial DNA of each isolate was amplified by PCR according to a method described by Wang et al. (2008) using 16S rDNA universal primers EUB 9-27f and EUB 1542r (5′-GAGTTTGATCCTGGCTCAG-3′) and (5′-AGAAAGGAG GTGATCCAGCC-3′). PCR products were sequenced by the Sanger’s method using an ABI PRISM 3500 xL Genetic Analizer (Applied Biosystems, Foster City, CA, USA). The sequences were analysed by means of Basic Local Alignment Search Tools (BLAST).

2.8. Antimicrobial Susceptibility Assay

Antimicrobial susceptibility tests were performed to the isolated strains obtained from water samples and RO membrane samples. The standard disk diffusion technique was carried out according to the recommendations of the Clinical Laboratory Standards Institute (National Committee for Clinical Laboratory Standards 2017). Isolated strains were incubated in 5 mL Tryptic Soy Broth (Becton Dickinson, Franklin Lakes, NJ, USA) for 18 h at 30 °C, serially diluted until reaching a turbidity similar to 0.5 McFarland. Each strain was disseminated in Petri dishes containing Müller–Hinton agar (Merck, Darmstadt, Germany). Neo-Sensitabs disks (Rosco, Taastrup, Denmark) used were ampicillin (10 mg), chloramphenicol (30 mg), tetracycline (30 mg), cefotaxime (30 mg), ciprofloxacin (5 mg), trimethoprim/sulfamethoxazole (1.25 mg/23.75 mg) and gentamicin (10 mg). Petri dishes were incubated overnight at 30 °C. Qualitative antimicrobial susceptibility patterns (S: Susceptible, I: Intermediate, or R: Resistant) were determined after measuring the diameters of inhibition halos. E. coli ATCC 25922 strain and P. aeruginosa ATCC 27853 strain were used as control.

2.9. Statistical Analysis

Clustering analysis and MDS were performed using the PRIMER V.6 software package (Plymouth Routines in Multivariate Ecology Research, Auckland, New Zealand). Statistical significance of variance in indexes was evaluated using a one-way ANOVA using GraphPad Prism 5 software (GraphPad Software, San Diego, CA, USA). p values equal to or less than 0.05 were considered as significant. Statistical significance of variance in indexes was evaluated with a one-way analysis of variance (ANOVA).

3. Results

3.1. Scanning Electron Microscopy (SEM) Observation of RO Membranes

SEM observations of the three segments of RO membranes for both haemodialysis centres showed the presence of bacterial biofilms on their surface, revealing the presence of thin fibrillar pili at the bacterial cell surfaces in the initial and final segments (A and C, respectively) (Figure 1 and Figure 2). Furthermore, it was observed that the biofilm of the membranes of both centres was composed of a heterogeneous microbial community.

3.2. Total Cell and Viable Heterotrophic Bacterial Counts

Total cell numbers were determined by DAPI staining. Regarding the total cell counts of the RO membranes of both centres, the results for the DCN centre were 4.1 × 107, 2.7 × 107 and 5.3 × 107 cells mL−1 for the segments DCN A, DCN B and DCN C, respectively. Similar counts were found in the southern centre, with figures of 2.1 × 107, 3.2 × 107 and 1.7 × 107 cells mL-1 for the segments DCS A, DCS B and DCS C, respectively. No significant differences were detected between the segments of the RO membranes (p > 0.05) from both dialysis centres. The heterotrophic bacterial counts of RO membrane segments DCN A, DCN B and DCN C were 2.1 × 104, 2.4 × 104 and 1.7 × 104 CFU mL−1, respectively. Similar counts were obtained from the RO membrane segments DCS A, DCS B and DCS C with figures of 3.3 × 104 and 3.8 × 104 and 1.2 × 104 CFU mL−1, respectively.
The results for the total bacterial counts in water samples were 6.4 × 102 and 7.3 × 103 cells mL−1 for DCN PW and DCN OW, respectively and 3.7 × 102 and 5.7 × 103 cells mL-1 for DCS PW and DCS OW. Furthermore, there was no significant difference between PW and OW (p > 0.05) samples. The results for the heterotrophic bacterial counts in water samples were 6 x 101 CFU mL-1 for DCN PW and 7.1 × 102 CFU mL−1 for DCN OW and 3 × 101 CFU mL−1 for DCS PW and 4.1 × 102 CFU mL−1 for DCS OW. No significant differences were detected when comparing the segments of the RO membranes from both dialysis centres (p > 0.05). Similarly, no significant differences were observed between PW and OW (p > 0.05) of both centres.

3.3. Analysis of Similarity of Bacterial Communities by DGGE

DGGE profile bands or operational taxonomic units (OTUs) were analysed using the Bray–Curtis correlation. A distance matrix was calculated, and a cluster analysis was performed which resulted in a multidimensional scaling (MDS). The MDS analysis of the banding patterns obtained by DGGE revealed that the sampled segments of the RO membranes showed a high degree of similarity between them, 98 and 95% for DCN and DCS, respectively (Figure 3 and Figure 4). Analysis of similarities (ANOSIM) analysis (R = 0.004, P = 0.3140/R = 0.008, P = 0.4540) showed that differences between abundance of OTUs were not significant. These results were consistent with the hierarchical cluster analysis (Bray–Curtis index), which clearly indicated the high similarity between the three segments of RO membrane of both dialysis centres. In addition, MDS analysis revealed that the sampled segments of the RO membranes showed a low degree of similarity, 60 and 65% with DCN-PW and DCS-PW, respectively (Figure 3 and Figure 4). ANOSIM analysis (R = 0.41, P=0.001/R = 0.23, P=0.001) determined significant differences between samples in terms of abundance of OTUs, for both dialysis centres.

3.4. Analysis of the Bacterial Communities’ Composition

The metagenomics analysis of the total DNA extracted from the segment of RO membranes and PW samples showed the relative abundances of the main phyla. The main phyla in the DCN RO membrane were Proteobacteria (49%), Planctomycetes (26%) and Acidobacteria (9%), while in the DCS RO membrane they were Proteobacteria (86%), Actinobacteria (5%) and Planctomycetes (3%). Regarding potable water, the main phyla in DCN PW were Proteobacteria (73%), Planctomycetes (12%) and Bacteroidetes (5%) and in DCS PW they were Proteobacteria (99.872%), Firmicutes (0.0401%) and Bacteroidetes (0.0327%) (Figure 5).
A Proteobacteria class differentiation analysis was performed. With respect to the membranes, the relative abundances in DCN RO were: α-proteobacteria (31%), β-proteobacteria (1%), γ-proteobacteria (1%), δ-proteobacteria (12%) and non-classified Proteobacteria (4%), while in the DCS RO membrane, they were α-proteobacteria (9%), β-proteobacteria (68%), γ-proteobacteria (7%) and δ-proteobacteria (2%). The results for potable water in DCN PW were α-proteobacteria (36%), β-proteobacteria (18%), γ-proteobacteria (6%), δ-proteobacteria (11%) and non-classified Proteobacteria (2%), while in DCS PW, they were α-proteobacteria (42%), γ-proteobacteria (55%) and non-classified Proteobacteria (3%) (Figure 5).

3.5. Identification of Isolates

A total of 29 morphologically different isolates were initially obtained from both dialysis centres (15 and 14 morphotypes for DCN and DNS, respectively). Subsequent microscopy, biochemical profiles and 16 s rRNA analyses suggested that some of these isolates likely belonged to the same taxa. Finally, 15 different isolates were identified. PCR products of 16s rDNA were sequenced by the Sanger’s method and processed by BLAST with 96%–98% identity. The closest GenBank matches of 16S rDNA sequences revealed the presence of genera Pseudomonas, Stenotrophomonas, Agrobacterium, Pigmentiphaga, Ralstonia, Arthrobacter and Bacteroides in DCN and Pseudomonas, Stenotrophomonas and Staphylococcus in DCS (Table 1).

3.6. Antimicrobial Susceptibility Analysis

Antimicrobial susceptibility tests were applied to strains isolated from RO membranes and water samples. The strains showed a broad resistance to antibiotics, it being higher for ampicillin, chloramphenicol and cefotaxime followed by trimethoprim/sulfamethoxazole, gentamicin, tetracycline and ciprofloxacin (Table 2). In addition, most of the isolates showed intermediate sensitivity to at least one of the antibiotics tested. The results showed that the bacterial strains belonging to the genera Pseudomonas and Staphylococcus showed higher levels of resistance to the antibiotics tested (Table 3).

4. Discussion

One of the important complications in patients receiving HD is bloodstream infection. HD patients have 26 times higher risk of bacteraemia than the general population, increasing the risk of systemic infections, hospitalization and patient death. The Centres for Disease Control and Prevention (CDC) and the American Society of Nephrology (Transforming Nephrology Dialysis Safety Initiative) have focused on finding methodologies for eliminating bloodstream infections in HD patients [16,17], indicating that there is a need to generate prophylactic measures to allow the reduction of infections in these patients.
The use of catheters is one of the main risk factors for acquiring infections in HD patients [16]. Since HD patients expose their circulatory system to approximately 300–400 L of water per week, the quality of the water used for this purpose plays an important assure a safe procedure [4]. Although dialysis centres have detailed protocols for the analysis of water to be used, its contamination with pathogenic microorganisms can occur due to the use of inappropriate water sources, to failures in the maintenance or disinfection of HD equipment and to problems in the water treatment system, such as the malfunction or RO membranes used to purify water [18].
RO is one of the most widely used techniques for treating water to make it suitable for HD. However, sometimes biofilms may develop on the membranes used in the purification process, affecting water treatment due to the decrease in the effectiveness of the permeate [19,20]. In this study, a microbiological analysis of water and RO membranes used for water purification for HD was done in two dialysis centres located in the north-central area (DCN) and south-central area (DCS) of Chile.
SEM of the RO membranes of both centres demonstrated the presence of a heterogeneous biofilm, similar to those described by other authors [21,22,23]. SEM analyses showed fibrillar structures (pili) similar to the curli structures described by other authors [24] in all the segments of RO membranes. These structures play an important role to sustain the biofilm, firmly anchoring bacteria, providing a remarkable stability to the biofilm to withstand prolonged strong hydrodynamic conditions without disruption.
The analysis of the bacterial community by a DGGE profile suggested that there were no differences in bacterial composition between the segments of the membranes of both centres; therefore, metagenomic analyses were performed by mixing total DNA extracted from the three segments of each RO membrane and from PW samples. Proteobacteria phylum was the predominant biofilm phylogenetic group in the RO membranes of both dialysis centres, being ubiquitously distributed in freshwater [3,23]. If the high relative abundance of Proteobacteria is compared to the strains isolated from the RO membranes it can be concluded that most biofilm forming Proteobacteria present on the membranes are non-cultivable or dormant bacteria. It must be also considered that the samples of RO membranes were obtained from RO membranes at the end of their useful life, largely exceeding six months of use, and the different capability of PW bacteria to form biofilms may considerably affect the proportion of particular bacterial species in the mature biofilm. Thus, the bacterial community present in a biofilm does not necessarily must replicate the bacterial diversity of the water. This is supported by the fact that chlorine and oligotrophic conditions can induce dormancy. Chen et al. [11] and Shahryari et al. [25] reported a high predominance of the Proteobacteria group in RO membranes and in osmosed water, respectively. Bereschenko et al. [3] analysed clone libraries of biofilm bacterial communities from different locations of a water treatment plant, detecting that the Proteobacteria phylum predominated in all clone libraries and β-proteobacteria class was the most abundant Proteobacteria class in tap water and treated water samples, while α-proteobacteria was the most abundant in biofilms attached to RO membranes. Therefore, our results do not agree with those of Bereschenko et al. [3], because the PW samples of both centres showed predominance of α-Proteobacteria, while in the case of RO membranes, one of the centres showed predominance of α-Proteobacteria and the other of β -Proteobacteria. One of the variables which may explain the different results of both studies might be the source of the water feed, surface fresh water in the case of Bereschenko and coworkers and potable water in the case of our study. Al-Ashhab et al. [19], by massive sequencing, determined that β-proteobacteria followed by γ-proteobacteria were the most abundant classes in biofilms formed in RO membranes, which agrees with the metagenomics of DCS RO membrane which showed a higher relative abundance of β-proteobacteria.
Heidarieh et al. [26], studying HD water reported bacterial genera similar to those found in our study. Furthermore, the bacterial genera identified in that study were mainly Gram-negative bacteria, which are commonly related to bacteraemia in patients undergoing HD [16,27]. Bereschenko et al. [3] also reported that most bacteria present in biofilms developed in RO systems are associated to bacteraemia. In our study, Pseudomonas, Stenotrophomonas and Straphylococcus genera were isolated from RO membranes. These bacterial genera are characterized by forming robust biofilms and being among the main agents associated with bloodstream infections in Chile [28,29,30,31].
Rastolnia spp. are considered emerging opportunistic pathogens associated mainly to bloodstream nosocomial infections [32]. We recovered Rastolnia sp from RO membranes and osmosed water. This bacterial genus has been characterized as inhabitant of humid environments, including distilled water used for respiratory care at a paediatric intensive care unit and water used for HD, and it was reported in HD patients with bacteraemia [33,34]. Furthermore, Pigmentiphaga, characterized for growing in aquatic environments, fresh water and wastewater [29], has been reported as associated to human infections [35] and we recovered Pigmentiphaga kullae in this study. To the best of our knowledge, no reports mention the isolation of members of this bacterial genus from water treatment systems in health care environments.
The bacterial diversity at genera level in the two-dialysis centres here studied was heterogeneous and Pseudomonas sp. was the bacterial genus most frequently isolated in all samples. There are reports showing that this bacterial genus is one of the main components of RO membrane biofilms, favoured by its high adhesion capacity due to alginate production [20,36]. Alginate is a bacterial exopolysaccharide whose mucous consistency allows bacteria to firmly adhere to surfaces and, in addition, it protects bacteria against antimicrobials, making it an important virulence factor for Pseudomonas [37].
The isolation of Pseudomonas spp. from biofilm RO membranes is of ecological importance, their exopolysaccharide production favouring biofilm formation and also helping the colonization by other microorganisms, negatively impacting the efficiency of RO membranes. In addition, Pseudomonas spp., within Gram-negative bacteria, is the etiological agent most frequently isolated in bloodstream infections of HD patients [38]. Staphylococcus spp is another bacterial genus of clinical interest identified, with a high frequency of isolation, in this study. This bacterial genus has also been described as one of the main microorganisms causing infections, including infections in the bloodstream, osteomyelitis and endocarditis, in HD patients [39,40]. Gil et al. [41], studying S. aureus biofilm infection in a murine model, showed that exopolysaccharide and extracellular matrix proteins protect bacteria against cells and components of the immune response (neutrophils, macrophages, antibodies and antimicrobial peptides).
It should be noted that the strains isolated from both dialysis centres in this study showed high percentages of resistance to ampicillin, chloramphenicol and cefotaxime. These results are of relevant clinical importance because antibiotics such as beta-lactams and chloramphenicol are the most widely used antimicrobials for the control of human infections, being prescribed in approximately 65% of patients suffering infections [42].
Presently, antibiotic resistance, particularly of Gram-negative bacteria, is an emerging problem and the presence of multi-drug resistant bacteria (resistant to at least one antibiotic from three different families of antibiotics [43,44]) in RO membrane biofilms is a major problem. Furthermore, biofilms offer environmental protection and also favour antimicrobial resistance by horizontal transfer of antibiotic resistance genes [45,46,47]. It is also known that microorganisms growing as biofilms develop tolerance to antimicrobials up to a thousand times more than planktonic ones [48]. In addition, subgroups of microorganisms with persistent cell characteristics, such as metabolic inactivity and morphological changes preventing the action of antimicrobials, have been described within biofilms [49,50].

5. Conclusions

Although the bacterial composition of biofilms associated to RO membranes depends on physical, chemical and biological factors determined that the bacterial biofilm associated to RO membranes of HD is diverse, with a predominance of the phylum Proteobacteria, and Pseudomonas sp. was the bacterial genus most frequently isolated. Furthermore, due to its potential virulence and the resistance to antibiotics detected in some of the bacterial species isolated from HD water and RO membranes in our study, they may represent a health risk for patients subjected to haemodialysis treatment.

Author Contributions

Conceptualization, J.-P.C., V.L.C., A.G., K.S.-A.; methodology, J.-P.C., V.L.C., R.M., P.A.; software, C.V., R.M. and V.L.C.; validation, V.L.C., R.M., C.T.S.; formal analysis, V.L.C., C.V., C.T.S., J.-P.C.; investigation, J.-P.C. and V.L.C.; resources, V.L.C.; data curation, C.V.; writing—original draft preparation, J.-P.C., A.G., K.S.-A., C.T.S., and V.L.C.; writing—review and editing, V.L.C., C.T.S., K.S.-A., P.A.; visualization, J.-P.C., R.M., K.S.-A., C.V., A.G., Í.F., P.A., C.T.S., V.L.C.; supervision, V.L.C.; project administration, Í.F., V.L.C.; funding acquisition, V.L.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by Grant 216.036.043.1.0, VRID, University of Concepcion, Chile.

Acknowledgments

The authors acknowledge the assistance of the staff of the Electron Microscopy Laboratory, University of Concepcion, Chile.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Jha, V.; Garcia-Garcia, G.; Iseki, K.; Li, Z.; Naicker, S.; Plattner, B.; Saran, R.; Wang, A.Y.; Yang, C.W. Chronic kidney disease: Global dimension and perspectives. Lancet 2013, 382, 260–272. [Google Scholar] [CrossRef]
  2. Kashiwagi, T.; Sato, K.; Kawakami, S.; Kiyomoto, M.; Takei, H.; Suzuki, T.; Genei, H.; Nakata, H.; Iino, Y.; Katayama, Y. The performance evaluation of endotoxin retentive filters in haemodialysis. J. Nippon Med. Sch. 2011, 78, 214–223. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Bereschenko, L.A.; Heilig, G.H.; Nederlof, M.M.; van Loosdrecht, M.C.; Stams, A.J.; Euverink, G.J. Molecular characterization of the bacterial communities in the different compartments of a full-scale reverse-osmosis water purification plant. Appl. Environ. Microbiol. 2008, 74, 5297–5304. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Coulliette, A.D.; Arduino, M.J. Hemodialysis and water quality. Semin. Dial. 2013, 26, 427–438. [Google Scholar] [CrossRef]
  5. Perez-Garcia, R.; Garcia, M.R.; Gonzalez, P.E.; Solozabal, C.C.; Ramirez, C.R.; Martin-Rabadan, P.; Sobrino, P.P.E.; Gallego, P.O.; Dominguez, J.; de la Cueva, M.E.; et al. Guideline for dialysate quality of Spanish Society of Nephrology (second edition, 2015). Nefrologia 2016, 36, e1–e52. [Google Scholar] [CrossRef] [Green Version]
  6. Flemming, H.-C.; Schaule, G.; Griebe, T.; Schmitt, J.; Tamachkiarowa, A. Biofouling—The achilles heel of membrane processes. Desalination 1997, 113, 215–225. [Google Scholar] [CrossRef]
  7. Herzberg, M.; Elimelech, M. Biofouling of reverse osmosis membranes: Role of biofilm-enhanced osmotic pressure. J. Membr. Sci. 2007, 295, 11–20. [Google Scholar] [CrossRef]
  8. Khan, M.M.; Stewart, P.S.; Moll, D.J.; Mickols, W.E.; Nelson, S.E.; Camper, A.K. Characterization and effect of biofouling on polyamide reverse osmosis and nanofiltration membrane surfaces. Biofouling 2011, 27, 173–183. [Google Scholar] [CrossRef] [Green Version]
  9. Arduino, M.J. Dialysis-Associated Complications and Their Control. In Bennett and Brachman’s Hospital Infections, 5th ed.; Jarvis, W.R., Ed.; Lippincott Williams and Wilkins: Philadelphia, PA, USA, 2007. [Google Scholar]
  10. Park, S.K.; Hu, J.Y. Assessment of the extent of bacterial growth in reverse osmosis system for improving drinking water quality. J. Environ. Sci. Health Part A 2010, 45, 968–977. [Google Scholar] [CrossRef]
  11. Chen, L.; Zhu, X.; Zhang, M.; Wang, Y.; Lv, T.; Zhang, S.; Yu, X. Profiling Total Viable Bacteria in a Hemodialysis Water Treatment System. J. Microbiol. Biotechnol. 2017, 27, 995–1004. [Google Scholar] [CrossRef] [Green Version]
  12. Guzmán-Fierro, V.; Moraga, R.; Leon, C.; Campos, V.; Smith, C.; Mondaca, M. Isolation and characterization of an aerobic bacterial consortium able to degrade roxarsone. Int. J. Environ. Sci. Technol. 2015, 12. [Google Scholar] [CrossRef] [Green Version]
  13. Mafla, S.; Moraga, R.; Leon, C.G.; Guzman-Fierro, V.G.; Yanez, J.; Smith, C.T.; Mondaca, M.A.; Campos, V.L. Biodegradation of roxarsone by a bacterial community of underground water and its toxic impact. World J. Microbiol. Biotechnol. 2015, 31, 1267–1277. [Google Scholar] [CrossRef] [PubMed]
  14. Campos, V.L.; Valenzuela, C.; Yarza, P.; Kampfer, P.; Vidal, R.; Zaror, C.; Mondaca, M.A.; Lopez-Lopez, A.; Rossello-Mora, R. Pseudomonas arsenicoxydans sp. nov., an arsenite-oxidizing strain isolated from the Atacama desert. Syst. Appl. Microbiol. 2010, 33, 193–197. [Google Scholar] [CrossRef] [PubMed]
  15. Leon, C.G.; Moraga, R.; Valenzuela, C.; Gugliandolo, C.; Lo Giudice, A.; Papale, M.; Vilo, C.; Dong, Q.; Smith, C.T.; Rossello-Mora, R.; et al. Effect of the natural arsenic gradient on the diversity and arsenic resistance of bacterial communities of the sediments of Camarones River (Atacama Desert, Chile). PLoS ONE 2018, 13, e0195080. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Suzuki, M.; Satoh, N.; Nakamura, M.; Horita, S.; Seki, G.; Moriya, K. Bacteremia in hemodialysis patients. World J. Nephrol. 2016, 5, 489–496. [Google Scholar] [CrossRef]
  17. Fisher, M.; Golestaneh, L.; Allon, M.; Abreo, K.; Mokrzycki, M.H. Prevention of Bloodstream Infections in Patients Undergoing Hemodialysis. Clin. J. Am. Soc. Nephrol. 2020, 15, 132–151. [Google Scholar] [CrossRef]
  18. Suzuki, M.N.; Fregonesi, B.M.; Machado, C.S.; Zagui, G.S.; Kusumota, L.; Suzuki, A.K.; da Costa, J.A.C.; Llopart, J.S.; Nadal, M.; Domingo, J.L.; et al. Hemodialysis water parameters as predisposing factors for anemia in patients in dialytic treatment: Application of mixed regression models. Biol. Trace Elem. Res. 2019, 190, 30–37. [Google Scholar] [CrossRef]
  19. Al Ashhab, A.; Sweity, A.; Bayramoglu, B.; Herzberg, M.; Gillor, O. Biofouling of reverse osmosis membranes: Effects of cleaning on biofilm microbial communities, membrane performance, and adherence of extracellular polymeric substances. Biofouling 2017, 33, 397–409. [Google Scholar] [CrossRef]
  20. Nagaraj, V.; Skillman, L.; Ho, G.; Li, D.; Gofton, A. Characterisation and comparison of bacterial communities on reverse osmosis membranes of a full-scale desalination plant by bacterial 16S rRNA gene metabarcoding. NPJ Biofilms Microbiomes 2017, 3, 13. [Google Scholar] [CrossRef]
  21. Al Juboori, R.Y.T. Biofouling in RO System: Mechanisms, monitoring and controlling. Desalination 2012, 302, 1–23. [Google Scholar] [CrossRef]
  22. Qureshi, B.; Zubair, S.; Sheikh, A.K.; Bhujle, A.; Dubowsky, S. Design and performance evaluation of reverse osmosis desalination systems: An emphasis on fouling modeling. Appl. Therm. Eng. 2013, 60, 208–217. [Google Scholar] [CrossRef]
  23. Vitzilaiou, E.; Stoica, I.M.; Knøchel, S. Microbial biofilm communities on Reverse Osmosis membranes in whey water processing before and after cleaning. J. Membr. Sci. 2019, 587, 117174. [Google Scholar] [CrossRef]
  24. Nakano, M.; Deguchi, T.; Kawamura, T.; Yasuda, M.; Kimura, M.; Okano, Y.; Kawada, Y. Mutations in the gyrA and parC genes in fluoroquinolone-resistant clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 1997, 41, 2289–2291. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Shahryari, A.; Nikaeen, M.; Hatamzadeh, M.; Vahid Dastjerdi, M.; Hassanzadeh, A. Evaluation of bacteriological and chemical quality of dialysis water and fluid in Isfahan, central Iran. Iran J. Public Health 2016, 45, 650–656. [Google Scholar] [PubMed]
  26. Heidarieh, P.; Hashemi Shahraki, A.; Yaghoubfar, R.; Hajehasani, A.; Mirsaeidi, M. Microbiological Analysis of Hemodialysis Water in a Developing Country. ASAIO J. 2016, 62, 332–339. [Google Scholar] [CrossRef]
  27. Novosad, S.A.; Lake, J.; Nguyen, D.; Soda, E.; Moulton-Meissner, H.; Pho, M.T.; Gualandi, N.; Bepo, L.; Stanton, R.A.; Daniels, J.B.; et al. Multicenter Outbreak of Gram-Negative Bloodstream Infections in Hemodialysis Patients. Am. J. Kidney Dis. 2019, 74, 610–619. [Google Scholar] [CrossRef]
  28. Otaíza, F. Informe de Vigilancia de Infecciones Asociadas a la Atención en Salud. In Ministerio de Salud, Departamento de Calidad y Formación Control de IAAS; Minsal: Santiago, Chile, 2017. Available online: www.minsal.cl/wp-content/uploads/2015/09/informe-vigilancia-2017.pdf (accessed on 15 July 2020).
  29. Lee, K.; Yoon, S.S. Pseudomonas aeruginosa Biofilm, a Programmed Bacterial Life for Fitness. J. Microbiol. Biotechnol. 2017, 27, 1053–1064. [Google Scholar] [CrossRef] [Green Version]
  30. Moormeier, D.E.; Bayles, K.W. Staphylococcus aureus biofilm: A complex developmental organism. Mol. Microbiol. 2017, 104, 365–376. [Google Scholar] [CrossRef] [Green Version]
  31. Trifonova, A.; Strateva, T. Stenotrophomonas maltophilia—A low-grade pathogen with numerous virulence factors. Infect. Dis. 2019, 51, 168–178. [Google Scholar] [CrossRef]
  32. Fang, Q.; Feng, Y.; Feng, P.; Wang, X.; Zong, Z. Nosocomial bloodstream infection and the emerging carbapenem-resistant pathogen Ralstonia insidiosa. BMC Infect. Dis. 2019, 19, 334. [Google Scholar] [CrossRef] [Green Version]
  33. Kendirli, T.; Ciftci, E.; Ince, E.; Incesoy, S.; Guriz, H.; Aysev, A.D.; Tutar, E.; Yavuz, G.; Dogru, U. Ralstonia pickettii outbreak associated with contaminated distilled water used for respiratory care in a paediatric intensive care unit. J. Hosp. Infect. 2004, 56, 77–78. [Google Scholar] [CrossRef] [PubMed]
  34. Tejera, D.; Limongi, G.; Bertullo, M.; Cancela, M. Ralstonia pickettii bacteremia in hemodialysis patients: A report of two cases. Rev. Bras. Ter. Intensiva 2016, 28, 195–198. [Google Scholar] [CrossRef] [PubMed]
  35. Bridger, N.; Drews, S.; Burdz, T.; Wiebe, D.; Pacheco, A.L.; Ng, B.; Bernard, K. Isolation and characterization of Pigmentiphaga-like isolates from human clinical material. J. Med. Microbiol. 2013, 62, 708–711. [Google Scholar] [CrossRef] [PubMed]
  36. Belila, A.; El-Chakhtoura, J.; Otaibia, M.; Muyzerc, G.; Gonzalez-Gila, G.; Saikalya, P.E.; van Loosdrechtb, M.C.M.; Vrouwenvelde, J.S. Bacterial community structure and variation in a full-scale seawater desalination plant for drinking water production. Water Res. 2016, 94, 62–72. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Chanasit, W.; Gonzaga, Z.J.C.; Rehm, B.H.A. Analysis of the alginate O-acetylation machinery in Pseudomonas aeruginosa. Appl. Microbiol. Biotechnol. 2020, 104, 2179–2191. [Google Scholar] [CrossRef] [PubMed]
  38. Loo, L.W.; Liew, Y.X.; Choong, H.L.; Tan, A.L.; Chlebicki, P. Microbiology and audit of vascular access-associated bloodstream infections in multi-ethnic Asian hemodialysis patients in a tertiary hospital. Infect. Dis. 2015, 47, 225–230. [Google Scholar] [CrossRef]
  39. Karanika, S.; Zervou, F.N.; Zacharioudakis, I.M.; Paudel, S.; Mylonakis, E. Risk factors for meticillin-resistant Staphylococcus aureus colonization in dialysis patients: A meta-analysis. J. Hosp. Infect. 2015, 91, 257–263. [Google Scholar] [CrossRef]
  40. Imaizumi, T.; Hasegawa, T.; Nomura, A.; Sasaki, S.; Nishiwaki, H.; Ozeki, T.; Shimizu, H.; Minatoguchi, S.; Yamakawa, T.; Yazawa, M.; et al. Association between staphylococcus aureus bacteremia and hospital mortality in hemodialysis patients with bloodstream infection: A multicenter cohort from Japanese tertiary care centers. Ther. Apher. Dial. 2017, 21, 354–360. [Google Scholar] [CrossRef]
  41. Gil, C.; Solano, C.; Burgui, S.; Latasa, C.; Garcia, B.; Toledo-Arana, A.; Lasa, I.; Valle, J. Biofilm matrix exoproteins induce a protective immune response against Staphylococcus aureus biofilm infection. Infect. Immun. 2014, 82, 1017–1029. [Google Scholar] [CrossRef] [Green Version]
  42. Bush, K.; Bradford, P.A. Beta-Lactams and beta-Lactamase Inhibitors: An Overview. Cold Spring Harb. Perspect. Med. 2016, 6. [Google Scholar] [CrossRef]
  43. Vasoo, S.; Barreto, J.N.; Tosh, P.K. Emerging Issues in Gram-negative Bacterial Resistance: An Update for the Practicing Clinician. In Mayo Clinic Proceedings; Elsevier: Amsterdam, The Netherlands, 2015; Volume 90, pp. 395–403. [Google Scholar] [CrossRef] [Green Version]
  44. Doi, Y.; Wachino, J.I.; Arakawa, Y. Aminoglycoside resistance: The emergence of acquired 16S ribosomal RNA methyltransferases. Infect. Dis. Clin. 2016, 30, 523–537. [Google Scholar] [CrossRef] [PubMed]
  45. Schroeder, M.; Brooks, B.D.; Brooks, A.E. The Complex Relationship between Virulence and Antibiotic Resistance. Genes 2017, 8, 39. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Ciofu, O.; Tolker-Nielsen, T. Tolerance and Resistance of Pseudomonas aeruginosa Biofilms to Antimicrobial Agents-How P. aeruginosa Can Escape Antibiotics. Front. Microbiol. 2019, 10, 913. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Penesyan, A.; Nagy, S.S.; Kjelleberg, S.; Gillings, M.R.; Paulsen, I.T. Rapid microevolution of biofilm cells in response to antibiotics. NPJ Biofilms Microbiomes 2019, 5, 34. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  48. Davies, D. Understanding biofilm resistance to antibacterial agents. Nat. Rev. Drug Discov. 2003, 2, 114–122. [Google Scholar] [CrossRef]
  49. Allison, K.R.; Brynildsen, M.P.; Collins, J.J. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 2011, 473, 216–220. [Google Scholar] [CrossRef] [Green Version]
  50. Jung, S.H.; Ryu, C.M.; Kim, J.S. Bacterial persistence: Fundamentals and clinical importance. J. Microbiol. 2019, 57, 829–835. [Google Scholar] [CrossRef]
Figure 1. Scanning Electron Microscopy (SEM) of the reverse osmosis (RO) membrane of the north-central area dialysis centre showing the presence of biofilm. (A): initial segment of RO membrane. (B): middle segment of RO membrane. (C): final segment of RO membrane. The scale bar is 5 μm, 10 μm and 5 μm, respectively.
Figure 1. Scanning Electron Microscopy (SEM) of the reverse osmosis (RO) membrane of the north-central area dialysis centre showing the presence of biofilm. (A): initial segment of RO membrane. (B): middle segment of RO membrane. (C): final segment of RO membrane. The scale bar is 5 μm, 10 μm and 5 μm, respectively.
Microorganisms 08 01418 g001
Figure 2. Scanning Electron Microscopy (SEM) of the reverse osmosis (RO) membrane of the south-central area dialysis centre showing the presence of biofilm. (A): initial segment of RO membrane. (B): middle segment of RO membrane. (C): final segment of RO membrane. The scale bar is 5 μm, 10 μm and 5 μm, respectively.
Figure 2. Scanning Electron Microscopy (SEM) of the reverse osmosis (RO) membrane of the south-central area dialysis centre showing the presence of biofilm. (A): initial segment of RO membrane. (B): middle segment of RO membrane. (C): final segment of RO membrane. The scale bar is 5 μm, 10 μm and 5 μm, respectively.
Microorganisms 08 01418 g002
Figure 3. Multidimensional scaling (MDS) of the Denaturing Gradient Gel Electrophoresis (DGGE) data matrix of bacteria 16s rRNA from reverse osmosis (RO) membrane segments and potable water of north-central area dialysis centre (DCN). Similarly, index was evaluated for percentage. DCN-A: initial segment of DCN RO membrane. DCN-B: middle segment of DCN RO membrane. DCN-C: final segment of DCN RO membrane. DCN-PW: DCN potable water.
Figure 3. Multidimensional scaling (MDS) of the Denaturing Gradient Gel Electrophoresis (DGGE) data matrix of bacteria 16s rRNA from reverse osmosis (RO) membrane segments and potable water of north-central area dialysis centre (DCN). Similarly, index was evaluated for percentage. DCN-A: initial segment of DCN RO membrane. DCN-B: middle segment of DCN RO membrane. DCN-C: final segment of DCN RO membrane. DCN-PW: DCN potable water.
Microorganisms 08 01418 g003
Figure 4. Multidimensional scaling (MDS) of the Denaturing Gradient Gel Electrophoresis (DGGE) data matrix of bacteria 16s rRNA from reverse osmosis (RO) membrane segments and potable water of south-central area dialysis centre (DCS). Similarly, index was evaluated for percentage. DCS-A: initial segment of DCS RO membrane. DCS-B: middle segment DCS RO membrane. DCS-C: final segment of DCS RO membrane. DCS-PW: DCS potable water.
Figure 4. Multidimensional scaling (MDS) of the Denaturing Gradient Gel Electrophoresis (DGGE) data matrix of bacteria 16s rRNA from reverse osmosis (RO) membrane segments and potable water of south-central area dialysis centre (DCS). Similarly, index was evaluated for percentage. DCS-A: initial segment of DCS RO membrane. DCS-B: middle segment DCS RO membrane. DCS-C: final segment of DCS RO membrane. DCS-PW: DCS potable water.
Microorganisms 08 01418 g004
Figure 5. Relative abundance (percentage) of sequences of bacterial phylogenetic groups and Proteobacteria subclasses present in potable water (PW) and reverse osmosis (RO) membranes of the north central area dialysis centre (DCN) and south-central area dialysis centre (DCS).
Figure 5. Relative abundance (percentage) of sequences of bacterial phylogenetic groups and Proteobacteria subclasses present in potable water (PW) and reverse osmosis (RO) membranes of the north central area dialysis centre (DCN) and south-central area dialysis centre (DCS).
Microorganisms 08 01418 g005
Table 1. Identification of heterotrophic bacterial strains isolated from both haemodialysis centres.
Table 1. Identification of heterotrophic bacterial strains isolated from both haemodialysis centres.
StrainClosest Relative SequencePhylumIdentity (%)Gen Bank
Access Number
DCN RO-3Pseudomonas sp.Proteobacteria98MH114031.1
DCN RO-5Pseudomonas veroniiProteobacteria95MH482963.1
DCN RO-6Stenotrophomonas maltophiliaProteobacteria96FN395264.1
DCN RO-7Agrobacterium tumefaciensProteobacteria98MG575921.1
DCN RO-12Pigmentiphaga kullaeProteobacteria98KR856352.1
DCN PW-4Ralstonia sp.Proteobacteria97MH844635.1
DCN PW-10Arthrobacter sp.Actinobacteria95JQ316230.1
DCN OW-7Bacteroides doreiBacteroidetes96CP008741.1
DCS RO-1Pseudomonas sp.Proteobacteria98MK883238.1
DCS RO9Staphylococcus sp.Firmicutes97LC435711.1
DCS RO-11Staphylococcus pasteuriFirmicutes98MG996881.1
DCS RO-17Pseudomonas fluorescensProteobacteria98EU434450.1
DCS PW-7Pseudomonas poaeProteobacteria97MG835964.1
DCS OW-3Stenotrophomonas sp.Proteobacteria97KP663381.1
DCS OW-7Stenotrophomonas sp.Proteobacteria98KY357351.1
DCN: north-central area dialysis centre; DCS: south-central area dialysis centre; potable water (PW) and of osmosed water (OW); reverse osmosis membrane (RO).
Table 2. Percentage of antibiotic resistance of the isolated bacterial strains from both haemodialysis centres.
Table 2. Percentage of antibiotic resistance of the isolated bacterial strains from both haemodialysis centres.
Antibiotics% Resistant Strains
Ampicillin69%
Chloramphenicol55%
Tetracycline24%
Cefotaxime53%
Ciprofloxacin15%
Trimethoprim/sulfamethoxazole38%
Gentamicin31%
Table 3. Antimicrobial susceptibility of bacterial genus isolated from both haemodialysis centres.
Table 3. Antimicrobial susceptibility of bacterial genus isolated from both haemodialysis centres.
Bacterial GenusAM 10CHL 30Te 30CTX 30CIP 5TSX 25GE 10
Pseudomonas67% (7/11)55% (6/11)27% (3/11)67% (7/11)18% (2/11)36% (4/11)18% (2/11)
Stenotrophomonas100% (4/4)50% (2/4)50% (2/4)50% (2/4)0% (0/4)25% (1/4)50% (2/4)
Agrobacterium100% (0/2)0% (0/2)0% (0/2)100% (2/2)0% (0/2)0% (0/2)50% (1/2)
Pigmentiphaga100% (2/2)0% (0/2)50% (1/2)100% (2/2)0% (0/2)0% (0/2)100% (2/2)
Ralstonia100% (2/2)50% (1/2)0% (0/2)0% (0/2)0% (0/2)50% (1/2)0% (0/2)
Archobacter0% (0/1)0% (0/1)0% (0/1)0% (0/1)0% (0/1)0% (0/1)0% (0/1)
Bacteroides50% (1/2)0% (0/2)0% (0/2)0% (0/2)0% (0/2)0% (0/2)50% (1/2)
Staphylococcus80% (4/5)40% (2/5)20% (1/5)40% (2/5)0% (0/5)100% (5/5)20% (1/5)
* E. coli ATCC 25922RSSSSSS
* P. aeruginosa ATCC 27853RRRRSRS
* Reference strains: R: resistant; S: sensitive

Share and Cite

MDPI and ACS Style

Cuevas, J.-P.; Moraga, R.; Sánchez-Alonzo, K.; Valenzuela, C.; Aguayo, P.; Smith, C.T.; García, A.; Fernandez, Í.; Campos, V.L. Characterization of the Bacterial Biofilm Communities Present in Reverse-Osmosis Water Systems for Haemodialysis. Microorganisms 2020, 8, 1418. https://doi.org/10.3390/microorganisms8091418

AMA Style

Cuevas J-P, Moraga R, Sánchez-Alonzo K, Valenzuela C, Aguayo P, Smith CT, García A, Fernandez Í, Campos VL. Characterization of the Bacterial Biofilm Communities Present in Reverse-Osmosis Water Systems for Haemodialysis. Microorganisms. 2020; 8(9):1418. https://doi.org/10.3390/microorganisms8091418

Chicago/Turabian Style

Cuevas, Juan-Pablo, Ruben Moraga, Kimberly Sánchez-Alonzo, Cristian Valenzuela, Paulina Aguayo, Carlos T. Smith, Apolinaria García, Ítalo Fernandez, and Víctor L Campos. 2020. "Characterization of the Bacterial Biofilm Communities Present in Reverse-Osmosis Water Systems for Haemodialysis" Microorganisms 8, no. 9: 1418. https://doi.org/10.3390/microorganisms8091418

APA Style

Cuevas, J. -P., Moraga, R., Sánchez-Alonzo, K., Valenzuela, C., Aguayo, P., Smith, C. T., García, A., Fernandez, Í., & Campos, V. L. (2020). Characterization of the Bacterial Biofilm Communities Present in Reverse-Osmosis Water Systems for Haemodialysis. Microorganisms, 8(9), 1418. https://doi.org/10.3390/microorganisms8091418

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop